Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Tongling Jieya Biologic Technology Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.25
31.27
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Tongling Jieya Biologic Technology Co Ltd hold over its rivals?
What risks and challenges
does Tongling Jieya Biologic Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Tongling Jieya Biologic Technology Co Ltd.
Provide an overview of the primary business activities
of Tongling Jieya Biologic Technology Co Ltd.
What unique competitive advantages
does Tongling Jieya Biologic Technology Co Ltd hold over its rivals?
What risks and challenges
does Tongling Jieya Biologic Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Tongling Jieya Biologic Technology Co Ltd.
Provide P/S
for Tongling Jieya Biologic Technology Co Ltd.
Provide P/E
for Tongling Jieya Biologic Technology Co Ltd.
Provide P/OCF
for Tongling Jieya Biologic Technology Co Ltd.
Provide P/FCFE
for Tongling Jieya Biologic Technology Co Ltd.
Provide P/B
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/S
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/GP
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/EBITDA
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/EBIT
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/OCF
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/FCFF
for Tongling Jieya Biologic Technology Co Ltd.
Provide EV/IC
for Tongling Jieya Biologic Technology Co Ltd.
Show me price targets
for Tongling Jieya Biologic Technology Co Ltd made by professional analysts.
What are the Revenue projections
for Tongling Jieya Biologic Technology Co Ltd?
How accurate were the past Revenue estimates
for Tongling Jieya Biologic Technology Co Ltd?
What are the Net Income projections
for Tongling Jieya Biologic Technology Co Ltd?
How accurate were the past Net Income estimates
for Tongling Jieya Biologic Technology Co Ltd?
What are the EPS projections
for Tongling Jieya Biologic Technology Co Ltd?
How accurate were the past EPS estimates
for Tongling Jieya Biologic Technology Co Ltd?
What are the EBIT projections
for Tongling Jieya Biologic Technology Co Ltd?
How accurate were the past EBIT estimates
for Tongling Jieya Biologic Technology Co Ltd?
Compare the revenue forecasts
for Tongling Jieya Biologic Technology Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Tongling Jieya Biologic Technology Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Tongling Jieya Biologic Technology Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Tongling Jieya Biologic Technology Co Ltd compared to its peers.
Compare the P/E ratios
of Tongling Jieya Biologic Technology Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Tongling Jieya Biologic Technology Co Ltd with its peers.
Analyze the financial leverage
of Tongling Jieya Biologic Technology Co Ltd compared to its main competitors.
Show all profitability ratios
for Tongling Jieya Biologic Technology Co Ltd.
Provide ROE
for Tongling Jieya Biologic Technology Co Ltd.
Provide ROA
for Tongling Jieya Biologic Technology Co Ltd.
Provide ROIC
for Tongling Jieya Biologic Technology Co Ltd.
Provide ROCE
for Tongling Jieya Biologic Technology Co Ltd.
Provide Gross Margin
for Tongling Jieya Biologic Technology Co Ltd.
Provide Operating Margin
for Tongling Jieya Biologic Technology Co Ltd.
Provide Net Margin
for Tongling Jieya Biologic Technology Co Ltd.
Provide FCF Margin
for Tongling Jieya Biologic Technology Co Ltd.
Show all solvency ratios
for Tongling Jieya Biologic Technology Co Ltd.
Provide D/E Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide D/A Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide Interest Coverage Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide Altman Z-Score Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide Quick Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide Current Ratio
for Tongling Jieya Biologic Technology Co Ltd.
Provide Cash Ratio
for Tongling Jieya Biologic Technology Co Ltd.
What is the historical Revenue growth
over the last 5 years for Tongling Jieya Biologic Technology Co Ltd?
What is the historical Net Income growth
over the last 5 years for Tongling Jieya Biologic Technology Co Ltd?
What is the current Free Cash Flow
of Tongling Jieya Biologic Technology Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Tongling Jieya Biologic Technology Co Ltd.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
CN |
T
|
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
|
2.4B CNY | 41.7 | |
FR |
![]() |
L'Oreal SA
PAR:OR
|
187B EUR | 29.2 |
|
UK |
![]() |
Unilever PLC
LSE:ULVR
|
117.2B GBP | 23.8 |
|
IN |
![]() |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 49.1 |
|
UK |
![]() |
HALEON PLC
LSE:HLN
|
34.7B GBP | 24.1 |
|
DE |
![]() |
Beiersdorf AG
XETRA:BEI
|
26.9B EUR | 29.5 |
|
JP |
![]() |
Kao Corp
TSE:4452
|
3T JPY | 27.9 |
|
US |
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
19B USD | -27.2 |
|
IN |
![]() |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR | -261.2 |
|
IN |
![]() |
Dabur India Ltd
NSE:DABUR
|
818.4B INR | 45.5 |
|
CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
73.4B HKD | 33.3 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
CN |
T
|
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
|
Average P/E:
33.8
41.7
|
N/A | N/A | |
FR |
![]() |
L'Oreal SA
PAR:OR
|
29.2
|
10%
|
2.9 |
|
UK |
![]() |
Unilever PLC
LSE:ULVR
|
23.8
|
15%
|
1.6 |
|
IN |
![]() |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
49.1
|
8%
|
6.1 |
|
UK |
![]() |
HALEON PLC
LSE:HLN
|
24.1
|
13%
|
1.9 |
|
DE |
![]() |
Beiersdorf AG
XETRA:BEI
|
29.5
|
13%
|
2.3 |
|
JP |
![]() |
Kao Corp
TSE:4452
|
27.9
|
10%
|
2.8 |
|
US |
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
Negative Multiple: -27.2 |
45%
|
N/A |
|
IN |
![]() |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
Negative Multiple: -261.2 | N/A | N/A |
|
IN |
![]() |
Dabur India Ltd
NSE:DABUR
|
45.5
|
9%
|
5.1 |
|
CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
33.3
|
N/A | N/A |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.